False
June 4, 2026
IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore how a tougher funding environment is sharpening focus on scalability, cost-efficiency, partnerships, and commercialization in advanced therapies
1 min read
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
All the latest Medicine Maker articles.
June 1, 2026
Verve reports phase 1 data for one-time PCSK9 base editing; plus: neuroprotective gene therapy, non-viral DNA delivery, tumour-activated CAR-T, and in vivo CAR-M
3 min read
May 29, 2026
Accelerating analytical data management for the next-generation laboratory
7 min read
May 28, 2026
IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore how automation, AI, closed systems, and smarter supply chain models are helping advanced therapies move toward scalable delivery
May 27, 2026
Balancing deep biological insight with the realities of development is now central to progress in advanced medicine
6 min read
May 26, 2026
Merck’s TROP2 ADC delivers a phase III win in endometrial cancer, as new golimumab biosimilars and an oral microbiome therapy move forward
7 min read
May 26, 2026
We speak with Carol Houts about advanced therapy manufacturing, modular cleanrooms, and the challenge of scaling GMP infrastructure
7 min read
May 25, 2026
Why CTMC CEO Jason Bock relishes the challenge of solving cell therapy’s most complex manufacturing and delivery problems
13 min read
May 25, 2026
REGENXBIO reports phase III AAV data in Duchenne; plus: adenoviral immunotherapy, preconditioning-free CAR-T, in vivo immune programming, and DNA-guided CRISPR
6 min read
May 22, 2026
A new series championing analytical scientists in pharma begins with Genentech’s rising star
7 min read
May 21, 2026
Veeva research reveals a stark gap between the insights biopharma captures and the actions it takes – highlighting a missed opportunity to improve patient outcomes
5 min read
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
False
